GREM1 and hepatocellular carcinoma: showed that exosomal Gremlin-1 from CAFs reduced the sensitivity of HCC cells to sorafenib and promotes epithelial-mesenchymal transition (EMT) by inhibiting the Wnt/β-catenin and BMP signaling pathways (134).